Trial Profile
Tolerability and pharmacokinetic outcomes after multiple doses of twice-daily aclidinium bromide in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jul 2011
Price :
$35
*
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacokinetics
- 19 Jul 2011 New trial record